• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Novo Nordisk’s once-weekly Sogroya gets CHMP recommendation

    PHARMABIZ

    Novo Nordisk: Once-weekly Sogroya receives CHMP positive opinion

    GLOBENEWSWIRE

    Novo Nordisk: Once-weekly Sogroya® (somapacitan) receives CHMP positive opinion

    PRESS RELEASE

    Sogroya data show potential as once-weekly treatment in GHD

    GLOBENEWSWIRE

    Novo Nordisk`s Biological Somapacitan-Beco Receives Supplemental Approval In US

    FDA

    Novo Nordisk’s Sogroya moves closer towards EU approval

    PHARMATIMES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.